Market Research Logo

Radiotherapy Device - Global Market Outlook (2016-2022)

Radiotherapy Device - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Radiotherapy Device market is accounted for $5.5 billion in 2015 and is expected to reach $9.1 billion by 2022 growing at a CAGR of 7.4% from 2015 to 2022. Radiotherapy being a painless treatment, increase in cancer patients and sophisticated diagnostic techniques are accelerating the market growth. The multiple side-effects of radiation therapy and shortage of trained personnel could hamper radiotherapy devices market growth. However, challenges in visualizing tumours will limit the radiotherapy device market growth.

External beam therapy is accounted for maximum share of the global radiotherapy market, followed by internal radiotherapy devices and systemic radiotherapy due to a high installation contracts for the Proton Therapy Device Segment. The prostate cancer application segment is expected to witness largest share in both external and internal radiotherapy market. North America is the largest market for radiotherapy devices followed by Europe. Asia-Pacific is expected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and favourable government activities.

Some of the key players in global Radiotherapy Device market are Accuray Incorporated, Coviden Plc., IBA Group, GE Healthcare, Elekta AB, IsoRay Medical, Inc., Nordion, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc, Mitsubishi Electric Corporation, Protom International Inc, Siemens Healthcare, C.R. BARD, Inc. Angiodynamics Inc, Toshiba Medical Systems Corporation, Shenzhen GeneMDx Biotech. Co., Ltd., Varian Medical Systems, Inc., IntraOp Medical, Inc, Theragenics Corporation, Vision RT Ltd, Koninklijke Philips N.V, Eckert & Ziegler BEBIG, Oncura, Inc. and Sirtex Medical Ltd.
Products Covered:
Internal Beam Radiotherapy
Cesium-131
Iodine-125
Palladium-103
Iridium-192
Electronic Brachytherapy
Applicators & Afterloaders
External Beam Radiation Therapy
Intensity Modulated Radiotherapy (IMRT)
Stereotactic Technology
Proton Beam Therapy
Image-Guided Radiotherapy (IGRT)
3D Conformal Radiotherapy (3D CRT)
Tomotherapy
Volumetric Modulated Arc Therapy (VMAT)
Adaptive Radiation Therapy (ART)
High-energy Linear Accelerators (LINACs)
Gamma Knife
CyberKnife
Other External Therapy
Systemic Radiation Therapy
Iobenguane (I-131)
Rhenium (Re-186)
Samarium (Sm-153)
Yttrium-90 (Y-90)
End Users Covered:
Security and Access Control Clinics
Ambulatory Surgical Centres
Hospitals
Applications Covered:
Brain cancer and Neurosurgery
Gynecological Cancer
Penile Cancer
Esophageal Cancer
Cervical Cancer
Breast Cancer
Prostate Cancer
Spine Cancer
Lung and pleura Cancers
Colorectal Cancer
Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.7 Emerging markets
3.8 Application Analysis
3.9 Product Analysis
3.10 End User Analysis
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Radiotherapy Device Market, By Product
5.1 Introduction
5.2 Internal Beam Radiotherapy
5.2.1 Cesium-131
5.2.2 Iodine-125
5.2.3 Palladium-103
5.2.4 Iridium-192
5.2.5 Electronic Brachytherapy
5.2.6 Applicators & Afterloaders
5.3 External Beam Radiation Therapy
5.3.1 Intensity Modulated Radiotherapy (IMRT)
5.3.2 Stereotactic Technology
5.3.3 Proton Beam Therapy
5.3.4 Image-Guided Radiotherapy (IGRT)
5.3.5 3D Conformal Radiotherapy (3D CRT)
5.3.6 Tomotherapy
5.3.7 Volumetric Modulated Arc Therapy (VMAT)
5.3.8 Adaptive Radiation Therapy (ART)
5.3.9 High-energy Linear Accelerators (LINACs)
5.3.10 Gamma Knife
5.3.11 CyberKnife
5.3.12 Other External Therapy
5.3.12.1 Intraoperative Radiation Therapy (IORT)
5.3.12.2 4-dimensional Radiotherapy (4D-RT)
5.3.12.3 Electron Beam Radiation Therapy
5.3.12.4 Neutron Beam Radiation Therapy
5.4 Systemic Radiation Therapy
5.4.1 Iobenguane (I-131)
5.4.2 Rhenium (Re-186)
5.4.3 Samarium (Sm-153)
5.4.4 Yttrium-90 (Y-90)
6 Global Radiotherapy Device Market, By End User
6.1 Introduction
6.2 Clinics
6.3 Ambulatory Surgical Centres
6.4 Hospitals
7 Global Radiotherapy Device Market, By Application
7.1 Introduction
7.2 Brain cancer and Neurosurgery
7.3 Gynecological Cancer
7.4 Penile Cancer
7.5 Esophageal Cancer
7.6 Cervical Cancer
7.7 Breast Cancer
7.8 Prostate Cancer
7.9 Spine Cancer
7.10 Lung and pleura Cancers
7.11 Colorectal Cancer
8 Global Radiotherapy Device Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.8 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.8 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Accuray Incorporated
10.2 Coviden Plc.
10.3 IBA Group
10.4 GE Healthcare
10.5 Elekta AB
10.6 IsoRay Medical, Inc.
10.7 Nordion, Inc.
10.8 RaySearch Laboratories AB
10.9 Mevion Medical Systems, Inc
10.10 Mitsubishi Electric Corporation
10.11 Protom International Inc
10.12 Siemens Healthcare
10.13 C.R. BARD, Inc.
10.14 Angiodynamics Inc
10.15 Toshiba Medical Systems Corporation
10.16 Shenzhen GeneMDx Biotech. Co., Ltd.
10.17 Varian Medical Systems, Inc.
10.18 IntraOp Medical, Inc
10.11 Theragenics Corporation
10.20 Vision RT Ltd
10.21 Koninklijke Philips N.V
10.22 Eckert & Ziegler BEBIG
10.23 Oncura, Inc.
10.24 Sirtex Medical Ltd
List of Tables
Table 1 Global Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
Table 2 Global Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
Table 3 Global Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
Table 4 Global Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
Table 5 Global Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
Table 6 Global Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
Table 7 Global Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
Table 8 Global Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
Table 9 Global Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
Table 10 Global Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
Table 11 Global Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
Table 12 Global Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
Table 13 Global Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
Table 14 Global Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
Table 15 Global Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
Table 16 Global Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
Table 17 Global Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
Table 18 Global Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
Table 19 Global Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
Table 20 Global Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
Table 21 Global Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
Table 22 Global Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
Table 23 Global Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
Table 24 Global Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
Table 25 Global Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
Table 26 Global Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
Table 27 Global Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
Table 28 Global Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
Table 29 Global Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
Table 30 Global Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
Table 31 Global Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
Table 32 Global Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
Table 33 Global Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
Table 34 Global Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
Table 35 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 36 Global Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 37 Global Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
Table 38 Global Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
Table 39 Global Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
Table 40 Global Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
Table 41 Global Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
Table 42 North America Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
Table 43 North America Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
Table 44 North America Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
Table 45 North America Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
Table 46 North America Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
Table 47 North America Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
Table 48 North America Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
Table 49 North America Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
Table 50 North America Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
Table 51 North America Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
Table 52 North America Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
Table 53 North America Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
Table 54 North America Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
Table 55 North America Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
Table 56 North America Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
Table 57 North America Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
Table 58 North America Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
Table 59 North America Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
Table 60 North America Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
Table 61 North America Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
Table 62 North America Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
Table 63 North America Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
Table 64 North America Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
Table 65 North America Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
Table 66 North America Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
Table 67 North America Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
Table 68 North America Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
Table 69 North America Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
Table 70 North America Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
Table 71 North America Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
Table 72 North America Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
Table 73 North America Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
Table 74 North America Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
Table 75 North America Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
Table 76 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 77 North America Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 78 North America Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
Table 79 North America Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
Table 80 North America Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
Table 81 North America Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
Table 82 North America Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
Table 83 Europe Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
Table 84 Europe Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
Table 85 Europe Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
Table 86 Europe Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
Table 87 Europe Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
Table 88 Europe Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
Table 89 Europe Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
Table 90 Europe Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
Table 91 Europe Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
Table 92 Europe Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
Table 93 Europe Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
Table 94 Europe Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
Table 95 Europe Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
Table 96 Europe Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
Table 97 Europe Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
Table 98 Europe Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
Table 99 Europe Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
Table 100 Europe Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
Table 101 Europe Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
Table 102 Europe Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
Table 103 Europe Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
Table 104 Europe Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
Table 105 Europe Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
Table 106 Europe Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
Table 107 Europe Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
Table 108 Europe Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
Table 109 Europe Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
Table 110 Europe Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
Table 111 Europe Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
Table 112 Europe Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
Table 113 Europe Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
Table 114 Europe Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
Table 115 Europe Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
Table 116 Europe Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
Table 117 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 118 Europe Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 119 Europe Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
Table 120 Europe Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
Table 121 Europe Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
Table 122 Europe Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
Table 123 Europe Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
Table 124 Asia Pacific Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
Table 125 Asia Pacific Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
Table 126 Asia Pacific Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
Table 127 Asia Pacific Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
Table 128 Asia Pacific Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
Table 129 Asia Pacific Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
Table 130 Asia Pacific Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
Table 131 Asia Pacific Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
Table 132 Asia Pacific Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
Table 133 Asia Pacific Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
Table 134 Asia Pacific Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
Table 135 Asia Pacific Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
Table 136 Asia Pacific Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
Table 137 Asia Pacific Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
Table 138 Asia Pacific Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
Table 139 Asia Pacific Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
Table 140 Asia Pacific Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
Table 141 Asia Pacific Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
Table 142 Asia Pacific Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
Table 143 Asia Pacific Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
Table 144 Asia Pacific Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
Table 145 Asia Pacific Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
Table 146 Asia Pacific Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
Table 147 Asia Pacific Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
Table 148 Asia Pacific Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
Table 149 Asia Pacific Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
Table 150 Asia Pacific Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
Table 151 Asia Pacific Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
Table 152 Asia Pacific Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
Table 153 Asia Pacific Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
Table 154 Asia Pacific Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
Table 155 Asia Pacific Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
Table 156 Asia Pacific Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
Table 157 Asia Pacific Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
Table 158 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 159 Asia Pacific Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 160 Asia Pacific Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
Table 161 Asia Pacific Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
Table 162 Asia Pacific Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
Table 163 Asia Pacific Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
Table 164 Asia Pacific Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)
Table 165 RoW Radiotherapy Device Market Analysis, by Region, (2013-2022) ($MN)
Table 166 RoW Radiotherapy Device Market Analysis, by Product, (2013-2022) ($MN)
Table 167 RoW Radiotherapy Device Market Analysis, by Internal Beam Radiotherapy, (2013-2022) ($MN)
Table 168 RoW Radiotherapy Device Market Analysis, by Cesium-131, (2013-2022) ($MN)
Table 169 RoW Radiotherapy Device Market Analysis, by Iodine-125, (2013-2022) ($MN)
Table 170 RoW Radiotherapy Device Market Analysis, by Palladium-103, (2013-2022) ($MN)
Table 171 RoW Radiotherapy Device Market Analysis, by Iridium-192, (2013-2022) ($MN)
Table 172 RoW Radiotherapy Device Market Analysis, by Electronic Brachytherapy, (2013-2022) ($MN)
Table 173 RoW Radiotherapy Device Market Analysis, by Applicators & Afterloaders, (2013-2022) ($MN)
Table 174 RoW Radiotherapy Device Market Analysis, by External Beam Radiation Therapy, (2013-2022) ($MN)
Table 175 RoW Radiotherapy Device Market Analysis, by Intensity Modulated Radiotherapy (IMRT), (2013-2022) ($MN)
Table 176 RoW Radiotherapy Device Market Analysis, by Stereotactic Technology, (2013-2022) ($MN)
Table 177 RoW Radiotherapy Device Market Analysis, by Proton Beam Therapy, (2013-2022) ($MN)
Table 178 RoW Radiotherapy Device Market Analysis, by Image-Guided Radiotherapy (IGRT), (2013-2022) ($MN)
Table 179 RoW Radiotherapy Device Market Analysis, by 3D Conformal Radiotherapy (3D CRT), (2013-2022) ($MN)
Table 180 RoW Radiotherapy Device Market Analysis, by Tomotherapy, (2013-2022) ($MN)
Table 181 RoW Radiotherapy Device Market Analysis, by Volumetric Modulated Arc Therapy (VMAT), (2013-2022) ($MN)
Table 182 RoW Radiotherapy Device Market Analysis, by High-energy Linear Accelerators (LINACs), (2013-2022) ($MN)
Table 183 RoW Radiotherapy Device Market Analysis, by Gamma Knife, (2013-2022) ($MN)
Table 184 RoW Radiotherapy Device Market Analysis, by CyberKnife, (2013-2022) ($MN)
Table 185 RoW Radiotherapy Device Market Analysis, by Other External Therapy, (2013-2022) ($MN)
Table 186 RoW Radiotherapy Device Market Analysis, by Systemic Radiation Therapy, (2013-2022) ($MN)
Table 187 RoW Radiotherapy Device Market Analysis, by Iobenguane (I-131), (2013-2022) ($MN)
Table 188 RoW Radiotherapy Device Market Analysis, by Rhenium (Re-186), (2013-2022) ($MN)
Table 189 RoW Radiotherapy Device Market Analysis, by Samarium (Sm-153), (2013-2022) ($MN)
Table 190 RoW Radiotherapy Device Market Analysis, by Yttrium-90 (Y-90), (2013-2022) ($MN)
Table 191 RoW Radiotherapy Device Market Analysis, by End User, (2013-2022) ($MN)
Table 192 RoW Radiotherapy Device Market Analysis, by Clinics, (2013-2022) ($MN)
Table 193 RoW Radiotherapy Device Market Analysis, by Ambulatory Surgical Centres, (2013-2022) ($MN)
Table 194 RoW Radiotherapy Device Market Analysis, by Hospitals, (2013-2022) ($MN)
Table 195 RoW Radiotherapy Device Market Analysis, by Application, (2013-2022) ($MN)
Table 196 RoW Radiotherapy Device Market Analysis, by Brain cancer and Neurosurgery, (2013-2022) ($MN)
Table 197 RoW Radiotherapy Device Market Analysis, by Gynecological Cancer, (2013-2022) ($MN)
Table 198 RoW Radiotherapy Device Market Analysis, by Penile Cancer, (2013-2022) ($MN)
Table 199 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 200 RoW Radiotherapy Device Market Analysis, by Esophageal Cancer, (2013-2022) ($MN)
Table 201 RoW Radiotherapy Device Market Analysis, by Cervical Cancer, (2013-2022) ($MN)
Table 202 RoW Radiotherapy Device Market Analysis, by Breast Cancer, (2013-2022) ($MN)
Table 203 RoW Radiotherapy Device Market Analysis, by Prostate Cancer, (2013-2022) ($MN)
Table 204 RoW Radiotherapy Device Market Analysis, by Lung and pleura Cancers, (2013-2022) ($MN)
Table 205 RoW Radiotherapy Device Market Analysis, by Colorectal Cancer, (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report